Bedel Financial Consulting’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	-$4K	–	821
2020 Q1	$4K	Buy	+100	New	+$4K	﹤0.01%	598